The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00284960|
Recruitment Status : Completed
First Posted : February 1, 2006
Last Update Posted : August 3, 2017
|Condition or disease|
|Erectile Dysfunction Metabolic Syndrome Insulin Resistance|
Insulin is a hormone produced by the body that lets sugar into the cells, where it is used for energy. Insulin resistance occurs when the body's cells have a decreased ability to react to insulin. This leads to an increase in insulin secretion. Over time, insulin resistance can lead to higher levels of sugar in the blood (diabetes), and can also contribute to obesity, high blood pressure, high cholesterol levels and heart disease. There are no simple tests to actually diagnose insulin resistance. Currently, the glucose tolerance test is used to diagnose IR, but it involves several blood draws over a 2-hour period. Another purpose of this study is to compare a blood test involving only one blood draw to the 2-hour glucose tolerance test, which involves several blood draws over a 2-hour period.
It is well known that diabetes often leads to erectile dysfunction. Because insulin resistance occurs before diabetes, it is possible that erectile dysfunction may occur in some individuals while they have insulin resistance, but before they develop diabetes. If this is true, it might be possible to use erectile dysfunction as a sign of insulin resistance, which may lead to more timely treatment of insulin resistance and may delay or prevent the development of diabetes, and the other problems mentioned above.
|Study Type :||Observational|
|Enrollment :||30 participants|
|Official Title:||The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction|
|Study Start Date :||June 2005|
|Actual Study Completion Date :||March 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00284960
|United States, Pennsylvania|
|Hershey Med Center|
|Hershey, Pennsylvania, United States, 17033|
|Principal Investigator:||J C Trussell, MD|